Podcast

Destigmatizing Urology: Dr. Winter discusses STDs/STIs

Author(s):

Urology Times staff

“We need to just approach STIs as the medical conditions they are because until we do, and until we take those stigmas away, people will truly have resistance to discussing it, hesitance to discussing it, and resistance to diagnosis and intervention,” says Ashley Winter, MD.

In this episode, Urology Times® Assistant Editor Janelle Hart spoke with Ashley Winter, MD. She discusses why the misconceptions of sexually transmitted diseases and infections are hindering patients from seeking appropriate care, and how urologists can help to rid of these misconceptions. Winter is a urologist at Kaiser Permanente in Portland, Oregon.

Related Videos
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
A. Lenore Ackerman, MD, PhD, answers a question during a Zoom video interview
Hospital waiting room with reception counter at medical facility | Image Credit: © visoot - stock.adobe.com
A. Lenore Ackerman, MD, PhD, answers a question during a Zoom video interview
Christian Moro, PhD, BSc, BEd, MBus, SFHEA, answers a question during a Zoom video interview
Woman talking with doctor | Image Credit: © rocketclips - stock.adobe.com
Ana Lidia Flores-Mireles, PhD, answers a question during a Zoom video interview
Christian Moro, PhD, BSc, BEd, MBus, SFHEA, answers a question during a Zoom video interview
doctor showing a patient some information on a digital tablet | Image Credit: © bongkarn - stock.adobe.com
Doctor consulting patient | Image Credit: © Pcess609 - stock.adobe.com
Related Content
ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy
November 1st 2024

ELIMINATE trial: uUTI regimen demonstrates initial tolerability, efficacy

Hannah Clarke
A rapid reduction in E coli in the urine was observed among 10 of 16 evaluable patients at 4 hours following the first treatment.
Key updates from the AUA/ASRM male infertility guideline amendment
September 23rd 2024

Key updates from the AUA/ASRM male infertility guideline amendment

Urology Times staff
In this episode, Robert E. Brannigan, MD, and Juan J. Andino, MD, MBA, discuss the recent amendment to the AUA/ASRM guideline on male infertility.
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
October 15th 2024

FDA approves IDE for study evaluating underactive bladder device

Benjamin P. Saylor
According to iota Biosciences, the device is “designed to deliver electrical stimulation directly to the bladder wall, inducing contractions that facilitate bladder emptying in individuals impacted by underactive bladder.”
Speaking of Urology: Dr. Winter on the use of vaginal estrogen
July 24th 2024

Speaking of Urology: Dr. Winter on the use of vaginal estrogen

Urology Times staff
In this episode of Speaking of Urology®, Ashley G. Winter, MD, discusses the use of vaginal estrogen.
FDA Advisory Committee meets to discuss NDA of oral sulopenem for uUTI
September 9th 2024

FDA Advisory Committee meets to discuss NDA of oral sulopenem for uUTI

Hannah Clarke
Follow Urology Times' coverage of the full-day FDA advisory committee meeting regarding Iterum Therapeutics' new drug application for oral sulopenem for uncomplicated urinary tract infection.
Female doctor talking with a female patient | Image Credit: © rogerphoto - stock.adobe.com
August 1st 2024

Novel antibiotic discovery tool holds promise to uncover more natural compounds

Philip Abbosh, MD, PhD Kate Gessner, MD, PhD
"Teixobactin, and more broadly, the iChip approach to novel antibiotic discovery, is an exciting development in infection control," write Philip Abbosh, MD, PhD, and Kate Gessner, MD, PhD.
© 2024 MJH Life Sciences

All rights reserved.